Document is current
Any future updates will be listed below
-
Authors
Frame, Gavin
Leong, Hon
Haas, Roni
Huang, Xiaoyong
Wright, Jessica
Emmenegger, Urban
Downes, Michelle
Boutros, Paul C.
Kislinger, Thomas
Liu, Stanley K.
-
Funding
Funding for this research was provided by:
Prostate Cancer Canada Movember Discovery Grant (D2017- 1811, D2017- 1811, D2017- 1811, D2017- 1811, D2017- 1811)
Canadian Institutes of Health Research (PJT-162384, PJT-162384, PJT-162384, PJT-162384)
Canadian Cancer Society Challenge Grant (grant #708133, grant #708133, grant #708133, grant #708133)
Prostate Cancer Canada Movember Rising Star (RS2014-03, RS2014-03, RS2014-03, RS2014-03)
EMBO Postdoctoral Fellowship ALTF (1131-2021)
Prostate Cancer Foundation Young Investigator Award (22YOUN32)
Prostate Cancer Foundation (20CHAS0)
Early Detection Research Network (1U2CCA271894-01 and 3U01CA214194-0552)
NIH Informatics Technology for Cancer Research (1U24CA248265-01)
- License Information
-
More Information
Article History
Received: 19 March 2024
Revised: 23 July 2024
Accepted: 27 July 2024
First Online: 21 August 2024
Competing interests
: PCB sits on the scientific advisory board of Intersect Diagnostics Inc., BioSymetrics Inc., Sage Bionetworks. All other authors declare no conflicts of interest.
: Ethics approval and written informed consent was obtained for the use of patient samples in accordance with the Declaration of Helsinki. Patient biopsy and cell derivation was performed under a Sunnybrook Health Sciences Centre approved Research Ethics Board study (REB#3463). All experimental protocols were performed in accordance with the institutional guidelines of Sunnybrook Health Sciences Centre.
